Best GLP-1 for Sleep Apnea: Zepbound and the Alternatives

For obstructive sleep apnea there is not really a ranking to make. Tirzepatide (Zepbound) is the first and only medication FDA-approved for the indication, which makes this less a comparison than a guide to accessing the one approved option — and to the coverage advantage that approval creates.

How We Assessed These

For OSA specifically, the assessment turns on indication match and coordination with sleep medicine.

Why Tirzepatide and Not the Others

Approval rests on the SURMOUNT-OSA program published in the New England Journal of Medicine (Malhotra et al., 2024). Among people with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the apnea-hypopnea index, body weight, and hypoxic burden.

Hypoxic burden matters most. Much of the long-term cardiovascular harm from OSA is thought to arise from repeated intermittent hypoxia, so reducing it addresses the mechanism linked to downstream risk. A 2025 meta-analysis found GLP-1 receptor agonists as a class significantly reduce the apnea-hypopnea index — but only tirzepatide carries the indication.

The Coverage Advantage Most Patients Miss

This is the practical reason the approval matters beyond sleep. Many plans that decline GLP-1s for weight loss alone will cover them for an approved medical indication. A documented diagnosis of moderate-to-severe OSA is exactly the kind of weight-related comorbidity that changes a prior authorization outcome.

If you have obesity plus loud snoring, witnessed apneas, or unexplained daytime sleepiness and have never had a sleep study, you may be carrying an undiagnosed condition that is both treatable and relevant to coverage.

Do Not Stop CPAP

CPAP works the first night. Tirzepatide works over months as weight falls. They are complementary, not interchangeable.

Untreated moderate-to-severe OSA carries real cardiovascular and accident risk. Any decision to reduce or stop CPAP should follow repeat sleep testing showing improvement, directed by a sleep clinician — not an assumption based on starting medication or losing weight.

Questions Worth Asking Before You Enrol

• Have I had a sleep study, and what is my AHI?
• Will you coordinate with my sleep clinician on repeat testing?
• Can an OSA diagnosis help my prior authorization?
• When, if ever, would reducing CPAP be considered?
• Is Zepbound specifically what is being prescribed?

A provider that answers these clearly is managing a treatment plan. One that deflects to a monthly price is selling a subscription.